Biotech

All Articles

A closer check out Fierce Biotech's Strong 15

.In this particular full week's episode of "The Best Pipe," our company are actually diving in to Fe...

Lilly encounters period 2 failure of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's event celebrating the approval of Alz...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable management hirings, shootin...

Lykos will certainly talk to FDA to reassess its own choice adhering to turndown of MDMA treatment for trauma

.Following an unsatisfactory presenting for Lykos Rehabs' MDMA applicant for post-traumatic stress d...

AN 2 one-halfs head count, quits stage 3 test after records dissatisfy

.AN2 Therapeutics is actually reconsidering its own business in action to uninspired midphase data, ...

Merck pays $700M for bispecific, snooping autoimmune opening and also chance to challenge Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand upfront to challenge Amgen in a blood cancer cell...

Gilead pays J&ampJ $320M to leave licensing bargain for seladelpar

.With Gilead Sciences on the verge of an FDA choice for its own liver ailment drug seladelpar, the p...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can easily see the business establishing outdoors tents at basecamp responsible for...

Entero laying off staff, leaving workplace and stopping briefly R&ampD

.Bed Liquidators has actually transformed Entero Therapies white colored as a slab. The collector go...

Exelixis falls ADC after deciding it is actually no suit for Tivdak

.Exelixis is quiting on its cells element (TF)- targeting antibody-drug conjugate after wrapping up ...